Research map: A Parsimonious Ultrasound Radiomics and Ki-67 Model for Estimating MammaPrint Risk Categorization in HR+/HER2− Early Breast Cancer

Back to the article

Papers in this map

  1. Gene expression profiling predicts clinical outcome of breast cancer · Laura van ‘t Veer · 2002 · 9673 citations · Cited by this paper
  2. Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab–Lenvatinib: A Retrospective Real-World Study · 2026 · Related
  3. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 · Aron Goldhirsch · 2011 · 3934 citations · Cited by this paper
  4. Trastuzumab Deruxtecan in Metastatic Urothelial Carcinoma with NGS-Detected ERBB2 Amplification: A Four-Patient Real-World Case Series · 2026 · Related
  5. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer · Joseph A. Sparano · 2018 · 2448 citations · Cited by this paper
  6. Early Adherence to Immunomodulators in Multiple Myeloma: Retrospective Observations from a Safety-Net Hospital · 2026 · Related
  7. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer · Fátima Cardoso · 2016 · 2100 citations · Cited by this paper
  8. Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options · 2026 · Related
  9. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 · Alan Stuart Coates · 2015 · 1866 citations · Cited by this paper
  10. Hyperbaric Oxygen Therapy for Late Radiation-Induced Duodenal Toxicity After Stereotactic Body Radiotherapy in a Patient with Cholangiocellular Carcinoma: A Unique Case Report · 2026 · Related
  11. Gene-Expression Signatures in Breast Cancer · Christos P. Sotiriou · 2009 · 1518 citations · Cited by this paper
  12. Older Age Does Not Have an Impact on Postoperative Complication Risk Following Transurethral Resection of the Bladder Tumor · 2026 · Related
  13. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer · Kevin Kalinsky · 2021 · 889 citations · Cited by this paper
  14. ESR1 Y537S Detected in a Brain Metastasis but Not in Plasma ctDNA in HR+/HER2-Low Metastatic Breast Cancer: A Case Report · 2026 · Related
  15. 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age · Martine J Piccart · 2021 · 374 citations · Cited by this paper
  16. Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives · 2026 · Related
  17. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021 · William John Gradishar · 2021 · 352 citations · Cited by this paper
  18. The Efficacy of Transcutaneous Electrical Acupoint Stimulation as an Adjunct to Standard Bladder Training for Bladder Emptying After Radical Hysterectomy for Cervical Cancer: A Randomized Controlled Trial · 2026 · Related
  19. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients · Fausto Petrelli · 2015 · 293 citations · Cited by this paper
  20. Response to Zona, E.E.; Israel, J.S. Toward Individualized Management: A Commentary on Perioperative Systemic Therapy Guidelines in Breast Cancer Surgery and Reconstruction. Comment on “Galuia et al. Perioperative Drug Management of Systemic Therapies in Breast Cancer: A Literature Review and Treatment Recommendations. Curr. Oncol. 2025, 32, 154” · 2026 · Related
  21. Radiomics in breast cancer: Current advances and future directions · Ying-Jia Qi · 2024 · 175 citations · Cited by this paper
  22. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers · Toulsie Ramtohul · 2023 · 130 citations · Cited by this paper
  23. Image biomarkers and explainable AI: handcrafted features versus deep learned features · Leonardo Rundo · 2024 · 90 citations · Cited by this paper
  24. Explainable AI (XAI) in image segmentation in medicine, industry, and beyond: A survey · Rokas Gipiškis · 2024 · 60 citations · Cited by this paper
  25. Radiogenomics: bridging the gap between imaging and genomics for precision oncology · Wenle He · 2024 · 56 citations · Cited by this paper
  26. Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative · Paolo Giorgi Rossi · 2021 · 46 citations · Cited by this paper
  27. Explaining explainability: The role of XAI in medical imaging · João Abrantes · 2024 · 34 citations · Cited by this paper
  28. Combining Radiomics and Autoencoders to Distinguish Benign and Malignant Breast Tumors on US Images · Zuzanna Magnuska · 2024 · 34 citations · Cited by this paper
  29. Breast Medical Oncologists' Use of Standard Prognostic Factors to Predict a 21-Gene Recurrence Score · Arif H. Kamal · 2011 · 29 citations · Cited by this paper
  30. Multi-modality radiomics diagnosis of breast cancer based on MRI, ultrasound and mammography · Jiao Wu · 2025 · 12 citations · Cited by this paper
  31. Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients · Bo Pan · 2023 · 9 citations · Cited by this paper
  32. Ultrasound Radiomics in Breast Cancer - A Literature Review · MB Yi Chen · 2021 · 4 citations · Cited by this paper
  33. Clinically relevant gene signatures provide independent prognostic information in older breast cancer patients · Miguel Castresana-Aguirre · 2024 · 4 citations · Cited by this paper
  34. Machine learning-based ultrasound radiomics for predicting risk of recurrence in breast cancer · Wei Fan · 2025 · 4 citations · Cited by this paper
  35. Diagnostic value of ultrasound radiomic features in differentiating benign and malignant breast lesions · Yuke Gong · 2025 · 4 citations · Cited by this paper
  36. Machine learning prediction of pathological complete response to neoadjuvant chemotherapy with peritumoral breast tumor ultrasound radiomics: compare with intratumoral radiomics and clinicopathologic predictors · Jiejie Yao · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)